A critical discovery in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor suppressor protein is frequently lost in several types of cancer, leading https://socialaffluent.com/story7596378/mini-antibodies-reactivate-the-p53-protein-a-promising-approach-for-cancer-treatment